ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

36,732Medicare Part D Prescriptions Filled, Including Refills

Rank: 22 out of 3593

$569K Total Retail Price of All Prescriptions

Rank: 496 out of 3593

1,729 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
70% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

2% of this provider’s 1,729 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 32,821 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$16 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
SIMVASTATIN 2,143 2,002 1 1
OMEPRAZOLE 1,516 1,344 2 5
LISINOPRIL 1,489 1,385 3 2
METFORMIN HCL 1,016 887 4 6
AMLODIPINE BESYLATE 975 905 5 3
RANITIDINE HCL 962 854 6 27
ATORVASTATIN CALCIUM 714 638 7 15
FOLBIC 684 576 10 8 290
LOSARTAN POTASSIUM 667 602 9 14
RENAL CAPS 643 611 10 112
VITAMIN D2 640 503 11 124
ALENDRONATE SODIUM 624 597 12 22
ATENOLOL 617 570 13 11
HYDROCHLOROTHIAZIDE 612 555 14 10
PANTOPRAZOLE SODIUM 584 519 15 45
LORATADINE 557 494 16 129
ALPRAZOLAM 541 492 17 37
METOPROLOL TARTRATE 538 475 18 8
DONEPEZIL HCL 520 513 19 31
TEMAZEPAM 496 454 20 56
GABAPENTIN 492 411 21 16
IBUPROFEN 479 424 22 43
FENOFIBRATE 474 389 23 39
ZOLPIDEM TARTRATE 473 434 24 12
ENALAPRIL MALEATE 428 377 25 38
VOLTAREN 409 356 26 85
AMMONIUM LACTATE 359 314 27 125
LOSARTAN-HYDROCHLOROTHIAZIDE 354 320 28 48
SYNTHROID 337 321 29 51
GLIPIZIDE 327 311 30 40
METOPROLOL SUCCINATE 326 297 31 19
SERTRALINE HCL 313 290 32 28
FOLIC ACID 312 271 33 117
FUROSEMIDE 284 272 34 9
WARFARIN SODIUM 275 231 35 18
TAMSULOSIN HCL 269 236 36 33
LISINOPRIL-HYDROCHLOROTHIAZIDE 263 245 37 26
NAPROXEN 260 222 38 68
TRAMADOL HCL-ACETAMINOPHEN 251 194 39 147
PRAVASTATIN SODIUM 249 222 40 13
FLUTICASONE PROPIONATE 236 205 41 32
CLONAZEPAM 235 205 42 164
CLOPIDOGREL 235 212 42 30
VIAGRA 231 208 44 84
LIDODERM 218 192 45 78
DIOVAN 206 183 46 46
LEVOTHYROXINE SODIUM 204 181 47 4
CARVEDILOL 202 201 48 23
CLOTRIMAZOLE-BETAMETHASONE 192 167 49 94
LORAZEPAM 187 169 50 98
PAROXETINE HCL 183 159 51 62
MELOXICAM 181 165 52 29
LOVASTATIN 179 148 53 20
GLYBURIDE 169 148 R 54 55
VENTOLIN HFA 169 129 54 80
DICLOFENAC SODIUM 161 135 56 74
PROCTOZONE-HC 161 148 56 209
FAMOTIDINE 157 152 58 70
BENZONATATE 149 133 10 59 377
LEVOXYL 144 133 60 111
LANSOPRAZOLE 144 126 60 113
CITALOPRAM HBR 144 141 60 25
KETOCONAZOLE 143 111 63 118
DILTIAZEM 24HR ER 141 121 64 177
CIALIS 140 119 65 176
NYSTATIN 134 116 66 167
AMLODIPINE BESYLATE-BENAZEPRIL 133 132 67 65
PLAVIX 133 130 67 42
DOXAZOSIN MESYLATE 130 126 69 63
FLUNISOLIDE 129 111 70 261
CLORAZEPATE DIPOTASSIUM 129 110 70 236
SINGULAIR 125 110 72 77
GOLYTELY 121 88 10 73 321
LANTUS SOLOSTAR 120 111 74 122
MI ACID 117 113 75 272
VERAPAMIL ER 116 95 76 99
BACLOFEN 115 89 77 109
Q-TUSSIN DM 115 101 77 314
TRAMADOL HCL 114 101 79 17
CETIRIZINE HCL 113 108 80 225
PENTOXIFYLLINE 112 101 81 149
METOCLOPRAMIDE HCL 112 106 81 145
BUTALBITAL-ACETAMINOPHEN-CAFFE 109 86 R 10 83 316
TRAZODONE HCL 108 93 84 53
NYSTATIN-TRIAMCINOLONE 108 92 84 203
AFEDITAB CR 105 92 86 298
FINASTERIDE 101 96 87 79
PHENAZOPYRIDINE HCL 100 90 88 350
LOPERAMIDE 98 83 89 277
ROBAFEN-DM CLEAR 97 87 90 241
CILOSTAZOL 95 80 91 163
SURE COMFORT 95 78 91 159
GLYBURIDE-METFORMIN HCL 94 85 R 93 95
CRESTOR 89 61 94 21
LANTUS 88 63 95 57
MONTELUKAST SODIUM 86 70 96 151
AZITHROMYCIN 85 74 97 34
ALLOPURINOL 81 71 98 35
KLOR-CON 10 79 68 99 114
CLONIDINE HCL 75 55 100 41
KLOR-CON M20 74 66 101 139
NEXIUM 74 70 101 36
ADVAIR DISKUS 72 72 103 47
ATENOLOL-CHLORTHALIDONE 69 59 104 191
ISOSORBIDE MONONITRATE ER 68 68 105 61
FLUOXETINE HCL 64 60 106 60
CICLOPIROX 63 53 107 170
ULTICARE 63 46 107 370
SULFAMETHOXAZOLE-TRIMETHOPRIM 63 57 107 102
ESCITALOPRAM OXALATE 60 59 110 71
MECLIZINE HCL 58 56 111 96
LANOXIN 58 58 111 223
CHLORDIAZEPOXIDE HCL 58 58 111 393
OXYBUTYNIN CHLORIDE 57 55 114 104
AVODART 57 57 114 180
BENICAR 56 56 116 131
AMITRIPTYLINE HCL 55 43 R 117 90
HYDRALAZINE HCL 54 46 118 107
MUPIROCIN 53 46 119 132
NIFEDIPINE ER 50 50 120 75
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 28, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.